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Abstract 
 
Objectives Intermittent periods of hypoxemia such as during periodic breathing are 
associated with hypertension and increased sympathetic activity. In patients with sleep 
apnea syndrome, hypertension is common. Treating apnea improves hypertension and 
reduces sympathetic outflow. The aim of the present study was to investigate the 
phenomenon and mechanisms of spontaneous periodic breathing in patients with 
hypertension. 
Method We examined 43 hypertensive patients with untreated hypertension without left 
ventricular dysfunction, heart failure or sleep apnea syndrome. Muscle sympathetic 
nerve activity (MSA), heart rate (HR), blood pressure (BP) and respiration were 
continuously recorded at rest and during cold pressor testing. Oxygen and a CO2-
enriched gas were used to test central and peripheral chemoreceptors, respectively. 
Baroreceptor gain was measured using the alpha method. 
Results 7 out of 43 patients showed spontaneous periodic breathing while awake. No 
difference in MSA, HR and BP was seen between patients with and without periodic 
breathing at rest except the breathing pattern. However, the cold pressor test caused a 
larger increase of MSA in patients with periodic breathing (203±62 vs. 62±8%, p<0.0001 by 
ANOVA), as well as systolic (46±6 vs. 25±3 mmHg, p=0.002) and diastolic BP (26±5 vs. 12±1 
mmHg, p=0.004, ANOVA). Baroreceptor gain was markedly higher in patients with periodic 
breathing. Chemoreceptor sensitivity was comparable. 
Conclusion Spontaneous periodic breathing is relatively common in patients with 
hypertension and is associated with greatly enhanced responses to cold pressor testing. 
We suggest increased baroreceptor gain and sympathetic outflow as a cause for the 
oscillatory respiration pattern via baro-respiratory coupling. 
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 Condensed Abstract 
Periodic breathing, which is associated with various cardiovascular diseases was found 
in a considerable number of hypertensive patients. Sympathetic and blood pressure 
reactivity in response to the cold pressor test was greatly enhanced and baroreceptor 
sensitivity was markedly higher in patients with periodic breathing while chemoreceptor 
sensitivity was comparable between the groups. Increased baroreceptor gain and 
sympathetic outflow is suggested to cause the oscillatory respiration pattern via baro-
respiratory coupling.  
 
 
Keywords: blood pressure-physiology; sympathetic nervous system; chemoreceptors-
physiology; baroreceptor-physiology. 
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INTRODUCTION 
 
The sympathetic nervous system (SNS) plays an important role in cardiovascular 
regulation. Its activity has important pathogenetic and prognostic impact in a wide 
spectrum of cardiovascular disorders. Thus, factors influencing the activity of the 
sympathetic nervous system are of major interest.  
Periodic breathing (PB) of central origin such as it occurs in heart failure has been 
described 150 years ago by Cheyne and Stokes and is an independent marker of an 
increased mortality.[1] It goes along with sympathetic activation; however the pattern of 
activation differs from obstructive apnea.[2] The resulting blood pressure elevation is 
blocked by the ganglionic blocker trimethaphan and thus neuronally mediated. Low-
pressure receptors do not substantially contribute to sympathetic activation since end-
expiratory breath holds and the sustained Mueller maneuver increase sympathetic 
activity to a similar extent despite different intra-thoracic pressure.[3]  
Recent animal experiments indicate that chronic intermittent hypoxia leads to 
hypertension. In a rat model, repetitive periods of hypoxia over 30 days caused 
hypertension persisting beyond the exposure to intermittent hypoxia.[4] In dogs, hypoxic 
episodes due to repetitive airway obstruction during sleep resulted in acute transient 
increases in nighttime blood pressure and eventually provoked a sustained daytime 
hypertension.[5]  
It is likely that the same mechanisms are valid in humans too, since obstructive sleep 
apnea leads to increased SNS activity and increased daytime blood pressure.[6-8] 
Obstructive breathing disorders are associated with cardiovascular diseases such as 
hypertension,[9-11] myocardial infarction,[12] stroke,[13] and heart failure.[14] When 
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treated with continuous positive airway pressure (CPAP) during sleep, daytime blood 
pressure and sympathetic activity decrease.[15, 16] Similarly, in medically treated 
patients with heart failure, treatment of coexisting obstructive sleep apnea by CPAP 
reduces systolic blood pressure, sympathetic activity, improves left ventricular 
function[17] and increases oxygen body stores[18], while mild hyperoxia did not reduce 
sympathetic drive indicating that peripheral chemoreceptors do not contribute to 
sympathetic activation.[19] Slowing respiratory rate with respiratory training in patients 
with heart failure decreased dyspnea and increased exercise performance.[20] Thus, 
there is evidence that intermittent periods of hypoxia - central or obstructive - lead to 
elevated blood pressure both in the short and long term.  
In the run-in placebo phase of a clinical trial we noticed an unexpected high prevalence 
of a periodic breathing pattern in awake hypertensive patients without heart failure or 
sleep disorder. The aim of the present study was to investigate the phenomenon and 
mechanisms of spontaneous PB in conscious patients with hypertension and to 
delineate its impact on sympathetic regulation. 
 
 5
METHODS 
 
Subjects 
We examined 43 patients (31 men, 12 women) with arterial hypertension (diastolic blood 
pressure 95 to 114 mmHg) at the end of a 3 weeks placebo washout phase of a 
randomized double blind trial.[21] Patients treated with vasoactive drugs, with heart 
failure, pulmonary or hepatic disease were excluded from the study. The study was 
approved by the local ethics committee and all subjects gave written informed consent 
prior to study begin. 
 
Measurements and Interventions 
Patients were studied fasting between 9 and 11 AM in a quiet, temperature–controlled 
room in the supine position at rest and during cold pressor test (CPT) as previously 
described.[22, 23] Muscle sympathetic activity (MSA), ECG, non-invasive blood 
pressure (Finapres, Ohmeda, Englewood, CO) and respiration (strain gauge) were 
continuously recorded using a LabView application, a MIO 16L (National Instruments, 
TX, U.S.A.) A/D conversion board and a Macintosh Computer (Apple Inc. Cupertino, CA, 
U.S.A.). The signals were sampled at 500 Hz and stored with 12-bit accuracy. Blood 
pressure was measured every 5 minutes during rest and every minute during CPT using 
a sphygmomanometer (Dynamap, Critikon, Tampa, FL, U.S.A.). Percent change of 
minute ventilation was estimated based on the strain gauge recording.  
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Sympathetic nerve activity 
Sympathetic nerve activity was recorded continuously using microneurography as 
previously described. In brief, electrical activity of muscle vasoconstrictor fibers was 
measured in the peroneal nerve, posterior to the fibular head by use of tungsten 
microelectrodes (shaft diameter 200 µm, tapering to an uninsulated tip of 1-5 µm).[24, 
25] A subcutaneous reference electrode was inserted 1 to 2 cm away from the recording 
electrode. The neural signal was amplified, filtered, rectified and integrated to obtain a 
mean voltage neurogram of sympathetic activity. 
Measurements were taken at rest and during CPT. For the CPT, patients were asked to 
immerge one hand into ice water (0 °C) up to the wrist for 2 minutes. We choose to use 
CPT as this test is a well-known stimulus for the sympathetic nervous system.[26] 
Moreover, during CPT there is a positive correlation between the increases in MSA and 
the increases in arterial pressure and this test may unmask an increased sympathetic 
nervous activity, which is one of the underlying mechanisms of hypertension. [26]  
 
Peripheral chemoreceptor testing.  
Patients with PB were given oxygen by mask (Intersurgical, England) to test peripheral 
chemoreceptors. After habituation to the mask, patients breathed room-air during 5 
minutes to obtain a baseline value. Then oxygen was administered at 6 l/min for 5 
minutes to deactivate peripheral chemoreceptors and test their contribution to the 
sympathetic drive. Oxygen was followed by room air for 5 minutes. Five hypertensive 
patients without PB underwent the same procedure as control. 
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Central chemoreceptor testing.  
Patients with PB and 6 hypertensive control subjects with normal breathing pattern were 
tested using 7% CO2 and 93% oxygen during 3 minutes over a mouthpiece to centrally 
stimulate respiration. Before the measurement, the subjects breathed room air over the 
mouthpiece to get used to the procedure. 
 
Baroreceptor function. Baroreceptor function was estimated using the alpha 
method.[27] [28] The alpha coefficient was calculated as the squared root of the ratio of 
R–R interval and SBP powers[28] in the frequency domain. This relies on the 
assumption that the ratio between R–R interval and SBP powers in the frequency 
regions where they are coherent is a reflection of baroreflex function.  
This method was validated by animal experiment and the [alpha] coefficient 
demonstrated a relatively close correlation between [alpha] coefficient values and the 
estimates of baroreflex-sensitivity obtained by i.v. bolus injection of phenylephrine or 
nitroglycerine.[28] 
 
Paced breathing.  
Paced breathing use increases reliability of heart rate variability analysis.[29] 
Therefore, in our study all patients with PB and 6 hypertensive control subjects were 
studied during spontaneous breathing and paced breathing (breathing at 15/min during 
3 minutes). 
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Echocardiography.  
To exclude systolic left ventricular-dysfunction, which is associated with PB, 
transthoracic echocardiography was performed in patients with PB. Systolic left-
ventricular function was derived from biplane apical views. Left-ventricular dimensions 
and mass were measured using parasternal M-mode imaging.[30] Diastolic left-
ventricular function was assessed using mitral valve inflow and pulmonary vein flow 
pattern. 
 
Exclusion of sleep apnea.  
The presence of sleep apnea was excluded by history using a standard screening 
questionnaire[31].  
 
Analyses 
PB was diagnosed by inspection of the original strain gauge tracing, by clinical 
observation and spectral analysis of the respiratory signal revealing a distinct low 
frequency peak. Periods of 3 minutes were taken to calculate the spectral power of the 
respiratory oscillations. A peak in the very-low-frequency range between 0.005 and 0.05 
Hz, containing more than one third of the total power of the respiratory signal was taken 
as objective criterion to confirm PB. 
The respiratory, blood pressure and MSA recordings of the healthy volunteers were 
analyzed by an investigator blinded to the history of the subject.[32] MSA-signal was 
evaluated with a program written in MatLab (The Mathworks Inc., Natick, MA).[21] The 
program detects the time of a burst, its amplitude and the area under the curve. 
Parameters are given as mean values of one minute. 
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Statistical analysis 
Data were analyzed with repeated-measures ANOVA (Bonferroni correction) for the 
CPT and paired Student’s t-tests for comparison of oxygen and room-air breathing. MSA 
during the CPT is given as per cent change compared to 3 minutes of baseline before 
CPT. The effects of oxygen breathing and CO2 breathing are given as change from 
baseline. Results are expressed as means±SEM. P<0.05 was considered statistically 
significant. 
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RESULTS 
Clinical characteristics 
Baseline characteristics such as heart rate, systolic and diastolic blood pressure and 
body mass index were comparable in patients with and without PB (Table 1). 
In 7 out of 43 hypertensive patients (16%) PB at rest was confirmed by a distinct very 
low frequency peak in the breathing spectrum, corresponding to a cycle length of 
approximately 35 seconds. In hypertensive patients with spontaneous PB, these very-
low-frequency oscillations did translate into corresponding very-low-frequency 
oscillations of heart rate and blood pressure (Figure 1). Echocardiography was 
performed in 6 of the 7 patients with PB. All of them had normal systolic function without 
regional wall motion abnormalities. Mean left ventricular muscle mass index was 121±9 
g/m2. Diastolic dysfunction (mitral inflow, pulmonary vein flow) was present in 5 out of 6 
patients. 
 
Cold pressor test 
Among the hypertensive study population, resting MSA did not differ between patients 
with PB and without PB (45.7±5 vs. 49.2±1.6 bursts/min, 73±6 vs. 75±2 bursts/100 
heart beats respectively, ns.). During CPT patients with PB showed a larger increase of 
MSA (+203±62 vs. +62±8%, p<0.0001, Figure 2 A), systolic (+46±6 vs. +25±3 mmHg, p=0.002) 
and diastolic blood pressure (+26±5 vs. +12±1 mmHg, p=0.004) compared to patients without 
PB (Figure 2 B). Heart rate similarly increased in patients with PB (+ 5.5±1.9 min-1, p=0.02 vs. 
baseline) and patients without PB (+6.6±0.9, p<0.0001 vs. baseline). 
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Peripheral chemoreceptor deactivation with O2 breathing 
Five minutes of oxygen breathing increased O2-saturation from 94.8+0.5% to 
98.3±0.4% (p<0.0001) and significantly decreased HR (-1.2±0.7 min-1, p=0.004 vs. 
baseline) in patients with PB and in patients without PB (-0.9±1.0 min-1, p=0.03 vs. 
baseline) (Table 2). Oxygen-breathing for 5 minutes slightly decreased diastolic blood 
pressure in patients without PB but had no effect on MSA.  
 
Central respiratory stimulation by CO2 breathing 
Central respiratory stimulation by breathing of CO2-enriched gas equally increased 
minute ventilation in patients with PB (96 ± 37 %, p < 0.05 vs. baseline) and in patients 
without PB (96 ± 32 %, p < 0.05 vs. baseline) as well as MSA (4.2±1.3 b/min, p=0.03 
and 87±40% of total activity, p=0.007) and (2.4±0.7 b/min, p=0.02 and 55±50% of total 
activity, p=0.03) respectively (Table 2). Systolic blood pressure increased in patients 
with PB by 4.4±1.5 mmHg, p=0.03 and in patients without PB (6.5±1.7 mmHg, p=0.009) 
without any difference between groups. Diastolic blood pressure remained unchanged 
in patients with PB (1.3±0.6 mmHg, ns.) and increased (3.1±1.2 mmHg, p=0.04) in 
patients without PB. Heart rate increased by 1.9±0.7 bpm in the group with periodic 
breathing (p=0.05 vs. baseline) and 1.4±0.7 bpm in the group without PB (p= ns.).  
 
Paced breathing 
Paced breathing (Table 2) resulted in a small decrease of MSA in patients with PB (-
1.8±0.6 b/min, p=0.04 vs. baseline) but not in patients with normal breathing. There was 
no significant change in systolic blood pressure. Diastolic blood pressure was 
unaffected in patients with PB and decreased by 3.2±0.8 mmHg in patients without PB 
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(p=0.009 vs. baseline). O2 saturation increased by 1.8±0.5% (p=0.003 vs. baseline) 
during paced breathing without intergroup difference. Paced breathing equally 
increased minute ventilation in patients with PB and without PB, respectively (107±35 % 
vs. 85±27 %, p=ns.). 
 
Baroreceptor function 
Baroreceptor sensitivity in the high frequency range was comparable in patients with PB 
(10.2±2.5 ms/mmHg) and patients without PB (10.5±1.2 ms/mmHg), whereas in the low 
frequency range the sensitivity was significantly higher in patients with PB (10.4±1.0 
ms/mmHg) compared to patients without periodic breathing (5.2±0.5 ms/mmHg, 
p<0.0001, Figure 3). 
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DISCUSSION 
 
This study shows that spontaneous PB is relatively common in awake hypertensive 
patients without sleep apnea, left ventricular dysfunction or heart failure. Spontaneous 
PB was associated with a markedly enhanced reactivity of blood pressure and 
sympathetic activity to a physiologic stimulus. The sympathetic response to the cold 
pressor test was markedly more pronounced compared to controls. An increased 
sympathetic nervous activity has a negative prognostic impact in patients with 
cardiovascular disease such as heart failure,[33] myocardial infarction,[34] and 
stroke.[35]  
Baroreceptor gain for slow changes of blood pressure was considerably higher in 
patients with PB representing increased controller gain in the baroreceptor feedback 
loop. 
Feedback systems are important elements of cardiorespiratory regulation. They consist 
of a controller (chemoreceptors, baroreceptors), a plant whose effect or output is 
regulated by the controller and a communication channel through which the controller is 
informed about the effect of the plant. Chemoreflexes are powerful modulators of 
breathing as well as of neural circulatory control. They are subject to important negative 
feedback interactions as chemoreceptors give important inputs for the regulation of the 
sympathetic nerve activity, while thoracic afferents inhibit sympathetic outflow. 
Our experiments support the hypothesis that cyclic inhibition of respiration by carotid 
and aortic baroreceptors contributes to oscillations in the breathing pattern of 
hypertensive patients. Indeed, the link between aortic and carotid baroreceptors and the 
control of the respiratory center has already been demonstrated by Heymans who was 
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awarded the Nobel prize in 1938. He showed that arterial hypertension in the cardio-
aortic vascular area and in the carotid artery inhibits the activity of the respiratory center 
by a reflex mechanism, while hypotension has stimulatory effects upon breathing.[36] 
Indeed, marked blood pressure surges were followed by cyclic depression of respiration 
or apnea in our patients. A study in patients with pacemakers and sleep apnea 
syndrome showed that the stabilization of heart rate and in turn blunting baroreceptor-
mediated oscillations of cardiac output by atrial overdrive pacing reduces the severity of 
the breathing disorder.[37] 
Conversely, central and peripheral chemoreceptors do not seem to be involved in the 
underlying sympathetic dysregulation, as CO2-breathing and hyperoxic deactivation of 
peripheral chemoreceptors led to similar respiration responses in our patients with and without 
PB. Baroreceptor gain in the low frequency range however, was twice as pronounced in patients 
with PB compared to the control group, indicating that arterial baroreceptors are much more 
sensitive to slow changes of blood pressure in patients with PB.  
Chemoreflex physiology is complex and the exact mechanisms by which both peripheral 
and central chemoreceptors are activated remains unclear. Periodic breathing of central 
origin is thought to origin from instability of the feedback circuit. Although such loops act 
to minimize effects of disturbances on the output, they can become oscillatory. In heart 
failure patients, periodic breathing is common and an increased sensitivity to CO2 has 
been found.[38] We hypothesized initially that an increased controller gain of 
chemoreceptors would be involved in respiratory oscillations, however, in patients with 
or without PB, CO2 sensitivity was comparable. Moreover, hyperoxic deactivation of 
peripheral chemoreceptors did not influence MSA in either of the groups but slightly 
lowered heart rate in both groups. The former finding is in line with the effect of oxygen 
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breathing in heart failure patients.[39] Thus, altered controller gain of central as well as 
peripheral chemoreceptors is not involved in PB in hypertensive patients.  
There is widespread evidence that hypoxia acutely increases sympathetic activity and 
consecutively peripheral resistance and blood pressure. The hypertensive effect of 
chronic intermittent hypoxia outlasts hypoxemia in animal models.[4, 5] Morgan et al. 
demonstrated in healthy volunteers that hypoxic hypercapnia leads to a protracted 
increase in MSA, whereas hyperoxic hypercapnia only transiently increases sympathetic 
activity indicating that hypoxemia is responsible for the effect.[40] Chronic intermittent 
hypoxia has thus clinically relevant prolonged effects on blood pressure in animal 
models.  
We used a strain gauge for the assessment of breathing. The strain gauge has several 
disadvantages compared to the pneumotachograph. Particularly, it does not allow exact 
quantification of respiratory volumes. However, the use of a mouthpiece as it is required 
with the pneumotachograph as well as the awareness of recording substantially 
influences the breathing pattern.[41] We aimed to identify irregularities in the breathing 
pattern with minimal awareness of the subjects of the recording rather than to exactly 
quantify respiratory flow. For this purpose, the strain gauge method used in this study 
might be more appropriate.  
 
Some limitations of our study have to be emphasized: as first the assessment of the 
baroreceptor function was based only on the low frequency/high frequency analysis, 
however, the use of paced breathing improved the reliability of spectral parameters such 
as LF/HF. 
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Moreover, even if CPT is a wide used test to increase sympathetic nervous activity this 
test presents indeed a large intraindividual variability (reliability) and a limited 
reproducibility.[42, 43] 
 
In summary our study provides evidence for the presence of PB in a considerable 
number of hypertensive patients. PB was associated with greatly enhanced responses 
to cold pressor testing, indicating a potentiation of sympathetic outflow. We suggest 
increased baroreceptor gain and sympathetic outflow as a cause for the oscillatory 
respiration pattern via baro-respiratory reflex mechanism. Increased gain of central and 
peripheral chemoreflexes does not seem to be an important cause. Further studies will 
define the incidence of PB as potential cause of arterial hypertension. In addition, 
interventional studies should be planned to clarify the potential therapeutic implications.  
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Figure Legends 
 
Figure 1: 
Original recording of respiration, heart rate, blood pressure, and muscle sympathetic 
nerve activity in a hypertensive patient with normal breathing or periodic breathing and 
spectral analysis of the same parameters. Note the oscillatory pattern of respiration, 
heart rate, blood pressure and muscle sympathetic nerve activity in periodic breathing. 
Abbreviations: HR: heart rate (1/min), BP: blood pressure (mmHg), MSA: muscle 
sympathetic nerve activity (V). 
 
Figure 2: 
A) Muscle sympathetic activity (MSA) during the cold pressor test (CPT) increases more 
markedly in patients with periodic breathing. 
B) Systolic and diastolic blood pressure (BP) changes during CPT. The blood pressure 
increase during CPT is more pronounced in patients with periodic breathing. 
 
Figure 3: 
Baroreceptor sensitivity in patients with (white bars) and without (black bars) periodic 
breathing in the high frequency (HF) and in the low frequency range (LF) calculated with 
the alpha method. Low frequency gain is markedly higher in patients with periodic 
breathing (p < 0.0001). 
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Table 1: Patient Characteristics (mean±SEM) 
 
 
(male/female) 
hypertensive patients 
Periodic breathing  
n=7 (6/1) 
hypertensive patients 
Control  
n=36 (24/12) 
Age [years] 53.3±4.7 59.8±1.4 
Body mass index [kg/m2] 28.7±1.5 27.1±0.6 
Systolic blood pressure [mmHg] 168.6±12.9 167.8±3.2 
Diastolic blood pressure [mmHg] 95.8±4.3 94.5±1.5 
Heart Rate [1/min] 61.9±3.3 65.3±1.8 
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Table 2: Effects of O2, CO2 and paced breathing (delta mean ± SEM vs. baseline) 
 
 
  O2   CO2   Paced 
Breathing
 
  p vs. 
baseline
p between 
groups 
 p vs. 
baseline 
p between 
groups 
 p vs. 
baseline 
p between 
groups 
 systolic BP mmHg          
Periodic 1.4±2.0 ns. 4.4±1.5 0.03 -4.2±2.7 ns. 
Non periodic 
-2.1±1.0 ns. ns. 6.5±1.7 0.009 ns. -3.8±1.6 0.06 ns. 
 diastolic BP mmHg          
Periodic -0.6±0.8 ns. 1.3±0.6  0.5±2.4 ns. 
Non periodic 
-2.4±0.9 0.03 ns. 3.1±1.2 0.04 ns. -3.2±0.8 0.009 0.14 
 HR bpm          
Periodic -1.2±0.7 0.004 1.9±0.7 0.05 0.1±0.4 ns. 
Non periodic 
-0.9±1.0 0.03 ns. 1.4±0.7 ns. ns. -1.1±1.3 ns. ns. 
 MSA b/min          
Periodic -0.2±1.3 ns. 4.2±1.3 0.03 -1.8±0.6 0.04 
Non periodic 
-0.1±0.5 ns. ns. 2.4±0.7 0.02 ns. -0.5±0.8 ns. ns. 
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